The initiative will provide funding to maintain high-quality health databases in the country and to support research that uses this data to advance understanding of cardiometabolic diseases (CMD). The aim
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
NLS News
The funding round was led by Voima Ventures, with co-leadership from existing investor Eir Ventures, bringing the total raised by the company to EUR 3.45 million EUR. This funding will
Together with Bpifrance, Trill Impact Ventures has co-led a USD 25 million series B financing round in May Health, a French-American medical device company targeting Polycystic Ovary Syndrome (PCOS) related
The company has announced an expansion of its pipeline through the nomination of PKCtheta as the target of a new immunology project. The PKCtheta kinase plays a critical role in
Tino Ebbers, professor in physiological measurements, receives the prize for his outstanding research at the Faculty of Medicine and Health Sciences at Linköping University. Tino Ebbers is awarded the Uncle
Xbrane Biopharma and STADA have entered into an exclusive licensing agreement with US biosimilars specialist Valorum Biologics for their ranibizumab biosimilar candidate. Valorum will pay a license fee of up
The double-digit million DKK investment is to set up a new storage and CTS production facility for the pharmaceutical and biotech industries. The expansion site is situated in the Greater
The European Commission (EC) has approved an indication extension for Aspaveli (pegcetacoplan) for treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia. Aspaveli is already approved
IRLAB Therapeutics has announced a collaboration agreement with the McQuade Center for Strategic Research and Development (MSRD), a member of the global Otsuka family of pharmaceutical companies. IRLAB and MSRD
EIT Health Scandinavia has presented a hub that connects researchers, clinicians and industry with European biobanks and health data registries. The platform, EIT Health Biobanks and Health Data Registries, provides
Sectra’s digital pathology solution together with Leica Biosystems, Imaging, Inc.’s Aperio GT 450 DX have received a 510(k) clearance by the FDA. This is the first time an FDA clearance
Karolinska Institutet’s president, Annika Östman Wernerson, and vice-president, Martin Bergö, have written an open letter to Sweden’s minister for foreign affairs and minister for education, calling on them to use
Astra Zeneca is terminating 200 jobs at the facility in Mölndal, reports Göteborgs-Posten. In a written comment, the company highlights that the number of employees has increased by several hundred
After a positive initial safety evaluation, the pioneering STEM-PD (stem cell-based transplant for Parkinson’s disease) clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing
Read the latest issue of our magazine!
No 02 2024 // This issue includes a special report on obesity, including an exclusive interview with professor Jens Juul Holst, discoverer of the now world-famous GLP-1, other Nordic obesity solutions beyond GLP-1, patient perspectives, investor perspectives, a market overview, and in-depth science articles about the field. Another theme in this issue is rare diseases, an area that has undergone a minor revolution in recent decades, and where Nordic collaboration, as well as patient perspectives and involvement, are crucial. In addition, it includes an exclusive interview with Anna Falk, Head of Lund University’s Center for Advanced Therapies, and you may learn more about the importance of embracing legalese as a drug developer. This, and much more!
Drug and Device Development
After a positive initial safety evaluation, the pioneering STEM-PD (stem cell-based transplant for Parkinson’s disease) clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing
The company has announced data from a non-clinical study exploring 177Lu-SN201 in a model for triple-negative breast cancer. In the model, 177Lu-SN201 demonstrates superior anti-tumor effect compared to standard cancer
The company has announced the initiation of the Phase 2 clinical trial VB-C-04. The trial evaluates VB10.16, the company’s off-the-shelf therapeutic cancer vaccine candidate for HPV16-positive cancers, alone or in
Predicting 2024
Nordic Life Science asked Lene Gerlach, Partner, Eir Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will
Nordic Life Science asked Casper Breum, Managing Partner, Sound Bioventures, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict
Nordic Life Science asked Ingrid Teigland Akay, Managing Partner, Hadean Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you
Nordic Life Science asked Dan Akschuti, Equity Partner/Biotech Analyst, Pareto Securities, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you
Nordic Life Science asked Pekka Simula, Partner, Innovestor Life Science, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict
Careers
Promotions and hefty raises do not create leaders. While some people always want to sit in the driver’s seat, leadership – effective leadership – is a learned skill. Too often
Jeanette Edblad is the new Director of the Office for Life Sciences at the Government Offices in Sweden. NLS asked her about her new role and about Swedish life sciences.
The board of WntResearch has appointed Per Norlén as the company’s new CEO. Per Norlén has solid experience from the life science industry in general and the development of cancer
Careers
Being part of a fast-paced industry where the technology is constantly evolving is part of what makes life science law an enjoyable challenge, said Attorney Hanna Paloheimo, who oversees the life sciences division at Castrén & Snellman Attorneys of Helsinki.
JOB ALERTS
Profile
When considering the significant industries in Norway, several obvious ones spring to mind: oil and gas, hydropower, property, and fishing. Life sciences would feature on very few lists, but that
In the heart of Iceland’s life sciences industry, Jonina Gudmundsdottir, the CEO of Coripharma, is making her mark. With a deep understanding of the industry’s challenges and a relentless drive
The CEO of Lundbeck, who announced that she will retire last week, did not initially intend to join the life science industry, but it captivated her more than 30 years
The latest research news from the Nordic region
Science articles
An international team of scientists led by the University of Helsinki performed comprehensive mapping of structural alterations in cellular proteins during the aging process. In the study published in Molecular
The 2023 Ig Nobel Prizes celebrates for example backward reading and counting nostril hairs. The 2023 Ig Nobel Prizes were awarded at the 33rd First Annual Ig Nobel Prize ceremony,
Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes. The findings are presented in the journal Nature Microbiology
Professor Jens Juul Holst has made discoveries that have strongly influenced how people with obesity or type 2 diabetes are treated today. Throughout a long career, this internationally recognized researcher
Professor Åslaug Helland is the recipient of the King Olav Vs Cancer Research Award 2023. “This is a great honor, and I am very happy about this recognition of the
In January 2023, the European Association for the Study of Obesity (EASO) and the Novo Nordisk Foundation (NNF) announced that they were establishing a new prize for an agenda-setting researcher
Nordic Life Science
The latest clinical trials
Sign up to our newsletter